Altman Clinical

Nov 1, 2024 | implementationscience.biomedcentral.com | Altman Clinical

ReferencesEmmons KM, Gandelman E. Translating behavioral medicine evidence to public policy. J Behav Med. 2019;42(1):84–94. Article  PubMed  PubMed Central  Google Scholar  Emmons KM, Chambers D, Abazeed A. Embracing policy implementation science to ensure translation of evidence to cancer control policy. Translational Behav Med. 2021;11(11):1972–9. Article  Google Scholar  Oh A, Abazeed A, Chambers DA.

Jul 29, 2024 | jamanetwork.com | Matthew Allen |Altman Clinical

Health care has expanded from the bedside to the desktop in the form of secure messaging via patient portals. At Kaiser Permanente, for instance, message exchanges increased 10-fold over a decade, comprising 25% of all primary care services.1,2 Concurrently, the Centers for Medicare & Medicaid Services have adapted billing options for messaging, provided they involve medical decision-making and 5 minutes of clinician time.

May 20, 2024 | jbc.org | Altman Clinical |Chuling Zhuang

ABSTRACTProtein Tyrosine Phosphatase Non-receptor type 22 (PTPN22) is encoded by a major autoimmunity gene and is a known inhibitor of T cell receptor (TCR) signaling and drug target for cancer immunotherapy. However, little is known about PTPN22 post-translational regulation. Here we characterize a phosphorylation site at Ser325 situated C-terminal to the catalytic domain of PTPN22, and its roles in altering protein function.

Oct 12, 2023 | implementationscience.biomedcentral.com | Altman Clinical

We describe this study using the Standards for Reporting Implementation Studies [24] (see Additional file 1). Relevant details are summarized here, but also see our published research protocol for more details [25]. All procedures were approved by the RAND Corporation IRB (Protocol #2020-N0887), including the use of data previously collected from organization-focused grantees [18, 19, 26] and new data collection from state-focused grantees.